Electronic research databases provider EBSCO Publishing (EBSCO), US, has announced that its evidence-based point-of-care clinical reference tool DynaMed has been rated highest in its category by healthcare providers. A new report on clinical decision support resources by KLAS, a research firm that specialises in monitoring and reporting the performance of healthcare vendors, rated disease reference tools in a number of categories. According to the report, DynaMed was rated 10 points higher in KLAS than any other disease reference product in the study.
In the KLAS survey, customers of each resource were surveyed in a variety of areas including credibility, relevance, electronic medical record (EMR) integration and influence on decisions, as well as standardisation of care and how well the resource met the overall needs of users. Survey respondents indicated that DynaMed excelled in the credibility of the information it provided and in the relevance of its information and bested the other two resources in 24 of 25 measures.
Disease references such as DynaMed are used by clinicians at the point of care to access the best available evidence for thousands of clinical topics. DynaMed is updated daily and can be integrated into any EMR system. It is used by more than half a million clinicians in over 125 countries. More than 4,000 physicians and other healthcare professionals across 60 specialties contribute to the resource and more than 200,000 medical articles are summarised in DynaMed - providing doctors and other healthcare providers with access to the latest clinical evidence.
Access to the latest clinical information at the point of care and within EMRs is having an impact on clinical decision support, which was the overall focus of the KLAS report.
Earlier in October 2011, DynaMed was named the most current point-of-care reference tool in a study published in the British Medical Journal. The study looked at how quickly five point-of-care products updated new evidence.
Search for more Decision Support Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
